Product ID |
Product Name |
CAS# |
Purity |
Y3310194 |
Puerarin-4'-O-ß-D-glucopyranoside |
117047-08-2 |
98% |
Y1262352 |
Nortanshinone |
97399-70-7 |
98% |
Y3309364 |
Suavissimoside R1 |
95645-51-5 |
98% |
Y1262405 |
Licorice-saponin H2 |
118441-85-3 |
99% |
Y3267884 |
2-Fluoro-5-phenylnicotinaldehyde |
1227582-82-2 |
95% |
Y3268198 |
2-Fluoro-6-methylphenylacetic acid |
886502-28-9 |
97% |
Y3267709 |
3-Carboxy-4-chloro-2-fluorophenylboronic acid |
1451393-04-6 |
95% |
Y3256056 |
4-Bromo-3-carboxyphenylboronic acid |
1451393-32-0 |
95% |
Y1249281 |
Eplivanserin (mixture) |
130581-13-4 |
99% |
Y3238543 |
OVA Peptide(257-264) TFA |
1262751-08-5 |
99% |
Y3242217 |
Pseudouridimycin |
1566586-52-4 |
89% |
Y1253576 |
PROTAC Mcl1 degrader-1 |
2163793-38-0 |
98% |
Y3305426 |
Apalutamide-COOH |
1332391-04-4 |
95% |
Y3289212 |
MI-3454 |
2134169-43-8 |
99% |
Y3289256 |
N-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-4-methoxy-1,3-benzothiazol-2-amine |
862974-22-9 |
99% |
Y3287856 |
Kaempferol-3-O-(6'''-trans-p-coumaroyl-2''-glucosyl)rhamnoside |
111957-48-3 |
98% |
Y3288655 |
Sarracenin |
59653-37-1 |
99% |
Y3254316 |
(6-Bromo-2-fluoro-3-iodophenyl)methanol |
1449008-03-0 |
95% |
Y3193792 |
1-[(azepan-1-yl)methyl]naphthalen-2-ol |
303790-97-8 |
98% |
Y3289241 |
ß-D-Glucopyranosyl abscisate |
21414-42-6 |
98% |
Y3285751 |
LY2812223 |
1311385-20-2 |
98% |
Y3290572 |
VERU-111 |
1332881-26-1 |
98% |
Y3297370 |
MC-Val-Cit-PAB-Indibulin |
2055896-95-0 |
97% |
Y3253772 |
Fmoc-Gly-Gly-Phe-OtBu |
236426-37-2 |
95% |
Y3310363 |
3,4-difluoro-N-(3-{3-methylimidazo[1,2-a]pyrimidin-2-yl}phenyl)benzamide |
862811-76-5 |
98% |
Y3242517 |
3-[(pyridin-2-yl)methyl]-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one |
422274-45-1 |
95% |
Y3249971 |
4-Hydroxy-4-methylcyclohexanecarboxylic acid |
90113-41-0 |
95% |
Y1253622 |
(3-Chlorobenzylidene)propanedinitrile |
2972-73-8 |
95% |
Y3249095 |
S 2-Amino-N-ethyl-butyramide hydrochloride |
187680-43-9 |
95% |
Y3250502 |
4-Amino-4-methyl-pentanoic acid ethyl ester hydrochloride |
2206264-52-8 |
95% |
Y3311235 |
Benzamide, N-(4-aminobutyl)-, hydrochloride (1:1) |
29833-51-0 |
95% |
Y3249831 |
2-Acetyl-5-fluoro-benzonitrile |
1363508-10-4 |
95% |
Y1253608 |
1-Bromo-3-cyclopropylmethoxy-5-trifluoromethyl-benzene |
1369928-61-9 |
95% |
Y3234688 |
3-Ethoxy-2,2-dimethyl-propionic acid |
125181-31-9 |
95% |
Y1341834 |
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-4-nitrobenzamide |
325778-74-3 |
96% |
Y3238295 |
1-Bromo-4-fluoro-2-(2,2,2-trifluoroethoxy)benzene |
870063-18-6 |
95% |
Y3247994 |
bio-THZ1 |
1604811-14-4 |
98% |
Y3247706 |
KB02-SLF |
2384184-40-9 |
99% |
Y3296233 |
(R)-VX-984 |
2448475-19-0 |
99% |
Y3239918 |
4-Amino-N-(cyclopropylmethyl)benzamide |
934524-22-8 |
95% |
Y1253624 |
N-Desmethyl-Apalutamide |
1332391-11-3 |
97% |
Y3306012 |
PIP4K-IN-a131 |
2055405-95-1 |
98.92% |
Y3267560 |
5-Chloro-N-methylpyridine-2-carboxamide |
1086110-81-7 |
95% |
Y3313747 |
4-(2-Bromo-5-(trifluoromethyl)phenyl)pyridine |
1443376-52-0 |
95%+ |
Y3269880 |
2-Ethoxy-4-methylbenzaldehyde |
154478-29-2 |
95% |
Y3250324 |
4-Amino-2,N-dimethyl-benzamide |
912838-54-1 |
95% |
Y3266776 |
3-Fluoro-2-isopropoxybenzaldehyde |
1037092-98-0 |
95% |
Y3233969 |
1-(2-Chloro-benzyl)-1H-pyrazol-4-ol |
1592296-18-8 |
95% |
Y3240160 |
1-Pentanamine, N-(phenylmethoxy)- |
471256-91-4 |
95% |
Y1249343 |
Carbamic acid, N-[trans-4-[2-[(methylsulfonyl)oxy]ethyl]cyclohexyl]-, 1,1-dimethylethyl ester |
917342-28-0 |
95% |
Y1339445 |
1-Bromo-4-((5-bromopentyl)oxy)benzene |
91130-83-5 |
95% |
Y3268672 |
Questinol |
35688-09-6 |
95% |
Y3238599 |
5-tert-Butoxycarbonylamino-4-fluoro-2-methyl-benzoic acid |
658085-43-9 |
95% |
Y3246718 |
4-Chloro-1-methyl-3,5-dinitro-1H-pyrazole |
84547-96-6 |
95% |
Y3314920 |
Methyl 2-chloro-5-nitro-4-(propan-2-yloxy)benzoate |
1143026-86-1 |
95% |
Y3241304 |
3-Cyclopentyl-2-methyl-propan-1-ol |
264258-62-0 |
95% |
Y3234867 |
(3-Bromo-phenoxy)-acetic acid tert-butyl ester |
277331-38-1 |
95% |
Y3270489 |
2,6-Dichloro-3-nitrophenylboronic acid pinacol ester |
1451391-07-3 |
95% |
Y3236715 |
Methyl 3,3-dicyano-2,2-dimethylpropanoate |
1228788-10-0 |
95% |
Y3238373 |
2-(4-Methoxypiperidin-1-yl)pyrimidin-4-amine |
1602075-12-6 |
95% |
Y3264374 |
5-Bromo-2-ethoxy-3-fluoro-benzaldehyde |
1823336-00-0 |
95% |
Y3265355 |
3-Methyl-2-phenylpyridine-5-carboxaldehyde |
1428234-46-1 |
95% |
Y3247551 |
5-Iodo-2-methylbenzyl bromide |
1261647-64-6 |
95% |
Y3254771 |
3-Benzyloxy-2-methyl-benzoic acid |
208986-50-9 |
95% |
Y3249317 |
1-(Ethylcarbamoyl)cyclopropanaminium hydrochloride |
1613690-20-2 |
95% |
Y1261801 |
2-(4-Hydroxybutyloxy)acetic acid tert-butyl ester |
475086-57-8 |
98% |
Y3262151 |
3-Fluoro-5-(propan-2-yloxy)benzoic acid |
1369879-36-6 |
95% |
Y3259861 |
5-Methyl-2-isopropoxybenzoic acid |
104216-91-3 |
95% |
Y1257366 |
Benzonitrile, 4-amino-2-(phenylmethoxy)- |
284044-40-2 |
95% |
Y3249597 |
MC-Val-Cit-PAB-Auristatin E |
2055896-77-8 |
96% |
Y3245514 |
CMF019 |
1586787-08-7 |
99% |
Y3252529 |
MC-VC-PABC-DNA31 |
1639352-03-6 |
98% |
Y3293755 |
(S,R,S)-AHPC-C8-NH2 |
2341796-79-8 |
98% |
Y3306593 |
Cetirizine Impurity B dihydrochloride |
1000690-91-4 |
99% |
Y3259023 |
4-[(2,6-Dichloropyridine-3-yl)methyl]mopholine |
1428234-56-3 |
95% |
Y3259144 |
3-(azepane-1-sulfonyl)-N-(1,3-benzothiazol-2-yl)benzamide |
690247-68-8 |
98% |
Y3234461 |
6-bromo-2-(3,4-dimethoxyphenyl)-4H-chromen-4-one |
54197-78-3 |
95% |
Y3286377 |
SPL-707 |
2195361-33-0 |
99% |
Y3292672 |
SNIPER(BRD)-1 |
2095244-54-3 |
99% |
Y3297707 |
PROTAC FLT-3 degrader 1 |
2230826-81-8 |
99% |
Y3237350 |
RIP1 kinase inhibitor 1 |
2095515-38-9 |
99% |
Y1266686 |
Abemaciclib metabolite M20 |
2138499-06-4 |
98% |
Y3237087 |
MRT00033659 |
1401731-54-1 |
99% |
Y1253728 |
PROTAC Bcl2 degrader-1 |
2378801-85-3 |
98% |
Y3256928 |
4-(4-Bromo-3-methoxybenzyl)morpholine |
1394291-37-2 |
95% |
Y3267712 |
N-(1,3-benzothiazol-2-yl)-3-chloro-1-benzothiophene-2-carboxamide |
330837-95-1 |
98% |
Y3269230 |
4-Fluoro-6-(methylthio)-1H-indazole |
1428234-74-5 |
95% |
Y3293476 |
Kanzonol C |
151135-82-9 |
90% |
Y3267393 |
5-Cyclopropyl-3-methoxypyridine |
1414870-78-2 |
95% |
Y1252991 |
Benzenesulfonamide, N,N,2-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1011731-93-3 |
91% |
Y3298153 |
4-Bromo-N-tert-butyl-3-fluorobenzamide |
303084-63-1 |
95% |
Y3269637 |
4-Bromo-2-chloro-N-cyclopropylbenzamide |
893420-20-7 |
95% |
Y3239776 |
[2-(4-Bromo-pyrazol-1-yl)-ethyl]-methyl-carbamic acid tert-butyl ester |
877399-67-2 |
95% |
Y3244667 |
6-(Cyclopropylcarbamoyl)pyridine-2-carboxylic acid |
1154984-73-2 |
95% |
Y1334899 |
[3-(3,4-Difluorophenyl)phenyl]methanamine |
1184009-21-9 |
98% |
Y3247313 |
6-(Ethylcarbamoyl)pyridine-2-carboxylic acid |
849669-84-7 |
95% |
Y3318413 |
7-Nitro-1H-indazole-5-carboxylic acid |
1352890-61-9 |
95%+ |
Y3234758 |
2-(2-Bromo-4-fluorophenyl)ethan-1-ol |
866029-22-3 |
95% |
Y3251772 |
2-Bromo-5-ethynyl-1,3-dimethoxybenzene |
2228428-05-3 |
95% |
Y3242221 |
[(3-Bromo-5-nitrophenyl)methyl](methyl)amine |
1251863-72-5 |
95% |